Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Translational application of pharmacogenomics for refractory lung cancer

ABSTRACT: Patient-derived cells (PDC) recapitulate the characteristics of lung cancer and its therapeutic response. We collected cancer cells of patients to receive various chemotherapy and performed integrative analysis for pharmachogenomics.

ORGANISM(S): Homo sapiens

PROVIDER: GSE165611 | GEO | 2022/01/03

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Translational application of pharmacogenomics for refractory lung cancer

Project description:Translational application of pharmacogenomics for refractory lung cancer

| PRJNA695241 | ENA

Neoadjuvant Chemotherapy +/- Bevacizumab Pharmacogenomics

Project description:<p>Neoadjuvant chemotherapy (NAC) for breast cancer is widely employed. We performed genome-wide association studies (GWAS) to determine if germline genetic variability was associated with benefits, in terms of pathological complete response (pCR), disease-free survival (DFS), and overall survival (OS), in patients entered on the NSABP B-40 NAC (National Surgical Adjuvant Breast and Bowel Project, B-40, Neoadjuvant Chemotherapy) trial where some patients were randomized to receive bevacizumab, in addition to chemotherapy. </p>

| phs001365 | dbGaP

Application of pharmacogenomics to vaccines.